Spiral: Home

It could also reflect a change in practice to treat high risk stage II colon cancer with adjuvant chemotherapy, or the addition of oxaliplatin in chemotherapy regimens19. Strengths and Limitations. This is the first study to use linked data from CPRD as the source and so we have been able to consider post-discharge complications leading to delays in treatment. The number of colon cancer ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download